| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), TCRT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 80.4K | $59.9K | - | |
| Dir | 70.3K | $52.3K | - | |
| CEO | 49.0K | $36.5K | - | |
| Dir | 44.7K | $33.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | Vieser Jaime | Director | Sell | 3,000 | $2.01 | $6,021.82 | -10.4% | -22.8% | +69.6% | |
| Sep 1, 2023 | Boyle Kevin S. Sr.48 | Chief Executive Officer | Sell | 68,014 | $0.14 | $9,542.36 | -7.9% | -54.0% | -88.0% | |
| Nov 29, 2022 | Postma Robert W | Director | Buy | 750,000 | $0.65 | $487,500.00 | +17.6% | -15.8% | -90.3% | |
| Nov 29, 2022 | Vieser Jaime | Director | Buy | 1,250,000 | $0.65 | $812,500.00 | New | -15.8% | -90.3% | |
| Dec 22, 2021 | De Groot Eleanor | EVP, Operations | Sell | 20,132 | $1.27 | $25,567.64 | -7.8% | -43.9% | -55.1% | |
| Nov 17, 2021 | Boyle Kevin S. Sr.48 | Chief Executive Officer | Buy | 10,000 | $1.40 | $14,000.00 | +1.1% | -31.2% | -25.0% | |
| Sep 29, 2021 | Vieser Jaime | Director | Buy | 100,000 | $1.91 | $191,000.00 | +16.5% | -42.2% | +3.1% | |
| Sep 2, 2021 | Hagen Heidi | Director | Buy | 23,770 | $1.76 | $41,835.20 | +19.5% | -28.2% | +63.8% | |
| Sep 2, 2021 | Postma Robert W | Director | Buy | 75,000 | $1.73 | $129,750.00 | +1.8% | -28.2% | +63.8% | |
| Sep 1, 2021 | Weis Holger | Director | Buy | 50,000 | $1.83 | $91,500.00 | +71.3% | -22.3% | +68.2% |